Latin America Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2018–2023)

Latin America Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2018–2023)

ID: 133 | Pages: 145 | October 2018 | Region: Latin America


Nuclear medicine falls under the field of Molecular Imaging, which involves use of a minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

Latin America Nuclear Medicine Radiopharmaceuticals Market is estimated at $0.85 billion in 2018 and is poised to reach $1.53 billion by 2023, growing at a CAGR of 12.4%.

Increasing incidence of cancer and cardiac ailments, immense technological advancements, increasing demand for SPECT and PET applications along with the growing public awareness for healthcare are fuelling the market growth for Radiopharmaceuticals. Further, Integration of X ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a major driving factor for the growth of the market. Strict regulatory frameworks pose a major hurdle to the translational research and clinical investigations. Reimbursement issues are other major issues blocking the growth of the market. In addition, shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are also restraining the Latin America nuclear medicine Radioisotopes market.

The market of radiopharmaceuticals is segmented into Diagnostic radioisotopes and Therapeutic radioisotopes. Diagnostic radioisotope market is further sub segmented into SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine) and PET (Fluorine-18, Rubidium-82) radioisotopes. Therapeutic radioisotopes cover Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177), Alpha Emitters (Radium-223) and Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192). By application market is segmented into (cardiology, lymphoma, thyroid, neurology oncology, and others). Furthermore, on the basis of geography, the Latin America Market is segmented into Argentina, Brazil and Mexico.

Radiopharmaceuticals market is the dominating segment and estimated to account for 90 % of the market while therapeutic radioisotopes contribute for 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18, Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have gained the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two other potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future growth of PET radioisotopes market.

Some of the key players influencing the Latin America nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 Brazil                                             

                6.3 Argentina                                    

                6.4 Mexico                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Nuclear Medicine Radiopharmaceuticals Market By Region, From 2018-2023 (USD Million)
  2. Latin America Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  3. Latin America Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Million)
  4. Latin America Therapeutic Radioisotopes Market By Region, From 2018-2023 (USD Million)
  5. Latin America Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  6. Latin America Cardiology Market By Region, From 2018-2023 (USD Million)
  7. Latin America Lymphoma Market By Region, From 2018-2023 (USD Million)
  8. Latin America Thyroid Market By Region, From 2018-2023 (USD Million)
  9. Latin America Neurology Market By Region, From 2018-2023 (USD Million)
  10. Latin America Oncology Market By Region, From 2018-2023 (USD Million)
  11. Latin America Other Applications Market By Region, From 2018-2023 (USD Million)
  12. Latin America Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  13. Latin America SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  14. Latin America PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  15. Latin America Other Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  16. Latin America SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  17. Latin America Technetium-99m Market By Region, From 2018-2023 ( USD Million )
  18. Latin America Thallium-201 Market By Region, From 2018-2023 ( USD Million )
  19. Latin America Gallium-67 Market By Region, From 2018-2023 ( USD Million )
  20. Latin America Iodine-23 Market By Region, From 2018-2023 ( USD Million )
  21. Latin America Other SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  22. Latin America PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  23. Latin America Fluorine-18 Market By Region, From 2018-2023 ( USD Million )
  24. Latin America Rubidium-82 Market By Region, From 2018-2023 ( USD Million )
  25. Latin America Other PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Million )
  26. Latin America Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  27. Latin America Beta Emitters Market By Region, From 2018-2023 ( USD Million )
  28. Latin America Alpha Emitters Market By Region, From 2018-2023 ( USD Million )
  29. Latin America Brachytherapy Market By Region, From 2018-2023 ( USD Million )
  30. Latin America Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  31. Latin America Iodine-131 Market By Region, From 2018-2023 ( USD Million )
  32. Latin America Yttrium-90 Market By Region, From 2018-2023 ( USD Million )
  33. Latin America Samarium-153 Market By Region, From 2018-2023 ( USD Million )
  34. Latin America Rhenium-186 Market By Region, From 2018-2023 ( USD Million )
  35. Latin America Lutetium-177 Market By Region, From 2018-2023 ( USD Million )
  36. Latin America Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  37. Latin America Radium-223 Market By Region, From 2018-2023 ( USD Million )
  38. Latin America Other Alpha Emitters Market By Region, From 2018-2023 ( USD Million )
  39. Latin America Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  40. Latin America Cesium-131 Market By Region, From 2018-2023 ( USD Million )
  41. Latin America Iodine-125 Market By Region, From 2018-2023 ( USD Million )
  42. Latin America Palladium-103 Market By Region, From 2018-2023 ( USD Million )
  43. Latin America Iridium-192 Market By Region, From 2018-2023 ( USD Million )
  44. Brazil Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  45. Brazil Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  46. Argentina Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  47. Argentina Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  48. Mexico Nuclear Medicine Radiopharmaceuticals Market By Type, From 2018-2023 (USD Million)
  49. Mexico Nuclear Medicine Radiopharmaceuticals Market By Application, From 2018-2023 (USD Million)
  50. Brazil Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  51. Argentina Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  52. Mexico Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  53. Brazil Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  54. Argentina Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  55. Mexico Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  56. Brazil SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  57. Argentina SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  58. Mexico SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  59. Brazil PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  60. Argentina PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  61. Mexico PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  62. Brazil Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  63. Argentina Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  64. Mexico Therapeutic Radioisotopes Market By Type, From 2018-2023 ( USD Million )
  65. Brazil Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  66. Argentina Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  67. Mexico Beta Emitters Market By Type, From 2018-2023 ( USD Million )
  68. Brazil Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  69. Argentina Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  70. Mexico Alpha Emitters Market By Type, From 2018-2023 ( USD Million )
  71. Brazil Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  72. Argentina Brachytherapy Market By Type, From 2018-2023 ( USD Million )
  73. Mexico Brachytherapy Market By Type, From 2018-2023 ( USD Million )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.